Press Releases

Results offer hope for the one-third of patients who do not respond well to many drugs. 

The study examined the use of pembrolizumab (Keytruda) to treat Merkel cell carcinoma.

Faculty from the department will also present their latest research findings.

One goal of the study was to reduce the frequency with which patients return to emergency rooms.

NYU Langone Transplant Institute rated top program in state for kidney, liver, and lung transplantation.

Among his goals are expanding innovative treatments for high-risk pregnancies.

Younger patients are being diagnosed at more advanced stages.

The treatment may offer a safe, portable option that people with cannabis use disorder can use daily.

Dr. Berman has joined NYU Langone Health to lead a new interventional psychiatry program.

Testing for loss of smell may be useful as a routine part of post-COVID care.